Liposomes and virosomes as immunoadjuvant and antigen-carrier systems in vaccine formulations
- 1 January 1998
- book chapter
- Published by Elsevier
Abstract
No abstract availableThis publication has 67 references indexed in Scilit:
- ‘Empty’ Ld molecules capture peptides from endocytosed hepatitis B surface antigen particles for major histocompatibility complex class I‐restricted presentationEuropean Journal of Immunology, 1996
- A new foreign policy: MHC class I molecules monitor the outside worldImmunology Today, 1996
- Liposomes containing lipid A as a potent non-toxic adjuvantResearch in Immunology, 1992
- The macrophage as the principal antigen-presenting cell for liposome-encapsulated antigenResearch in Immunology, 1992
- Liposomes as immunological adjuvants: approaches to immunopotentiation including ligand-mediated targeting to macrophagesResearch in Immunology, 1992
- Immunologic aspects of liposomes: presentation and processing of liposomal protein and phospholipid antigensBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1992
- Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro.The Journal of Experimental Medicine, 1992
- Immunological adjuvants: a role for liposomesImmunology Today, 1990
- Antigen Recognition by Class I-Restricted T LymphocytesAnnual Review of Immunology, 1989
- T cell tolerance by clonal elimination in the thymusCell, 1987